Updated Results from ALTER-S002: A Single-Arm Multicenter Trial of the Combination of Anlotinib with Chemotherapy in Patients with Stage IIB Classic Osteosarcoma of the Extremity.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要